Skip to main content
MedWatcherBeta

Loading research and source information…

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk for Type 2 diabetes: evidence and status · MedWatcher